QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer 会议论文 作者:  Mamounas, Eleftherios P.;  Geyer, Charles E., Jr.;  Huang, Chiun-Sheng;  Mano, Max S.;  Loibl, Sibylle 收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05 Phase III study of trastuzumab emtansine (T-DM1) vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy including trastuzumab: Primary results from KATHERINE 会议论文 作者:  Geyer, C. E., Jr.;  Huang, C-S;  Mano, M. S.;  Loibl, S.;  Mamounas, E. P. 收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05 Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06) 会议论文 ANNALS OF ONCOLOGY, 2017-09-01 作者:  Lambertini, M.;  Campbell, C.;  Bines, J.;  Korde, L.;  Delso, M. A. Izquierdo 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L) or their combination (L plus T) in the adjuvant tre 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Moreno-Aspitia, Alvaro;  Holmes, Eileen McCormick;  Jackisch, Christian;  De Azambuja, Evandro;  Boyle, Frances M. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Survival outcomes of the NeoALTTO study: Updated results of a randomized multicenter phase III neoadjuvant trial 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Huober, Jens Bodo;  Holmes, Eileen McCormick;  Baselga, Jose;  De Azambuja, Evandro;  Untch, Michael 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/04 The impact of early lapatinib-induced rash on disease-free and overall survival in patients treated within the ALTTO phase Ill randomized trial 会议论文 CANCER RESEARCH, 2016-02-15 作者:  Azim, H. A., Jr.;  Sonnenblick, A.;  Agbor-Tarh, D.;  Bradbury, I.;  Daly, F. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 DISEASE-FREE SURVIVAL (DFS) IN THE LAPATINIB ALONE ARM AND EXPANDED RESULTS OF THE PHASE III ALTTO TRIAL (BIG 2-06; NCCTG (ALLIANCE) N063D) IN THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER (EBC) 会议论文 ANNALS OF ONCOLOGY, 2014-09-01 作者:  Perez, E. A.;  Holmes, E.;  De Azambuja, E.;  Dueck, A.;  Baselga, J. 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/13